-
Angiotensin II: Mechanism and Research Guide
2026-09-02
Angiotensin II is an endogenous octapeptide and potent vasopressor used to model receptor signaling, oxidative stress, vascular remodeling, and hypertension mechanisms. The sequence Asp-Arg-Val-Tyr-Ile-His-Pro-Phe activates angiotensin receptors and supports controlled in vitro and in vivo cardiovascular research.
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-09-02
The reference study identifies the long non-coding RNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 in non-small cell lung cancer. Its knockdown enhanced ZC3H12A-mediated IL-6 mRNA degradation, reducing tumor-cell proliferation, migration, and tumor-associated macrophage-related effects.
-
D-Luciferin: Reading Biological State in Real Time
2026-09-01
D-Luciferin potassium salt can convert luciferase activity into a dynamic optical readout. This article connects assay design with new insights into spatially redirected plant defense metabolism, clarifying what bioluminescence can—and cannot—measure.
-
ω-Agatoxin IVA and Excitotoxicity in Cortical Neurons
2026-09-01
Lustig, Ahern, and Greenberg tested whether blocking P- and Q-type voltage-gated calcium channels with ω-agatoxin IVA protects cortical neurons from excitotoxic injury. The antagonist failed to reduce toxicity triggered by veratridine, ouabain, or NMDA, showing that suppression of presynaptic glutamate release is not necessarily sufficient to prevent rapid neuronal damage.
-
N1-Methylpseudouridine for CRISPRa mRNA Workflows
2026-08-31
Use N1-Methylpseudouridine to improve expression from CRISPRa mRNA while keeping splice-variant assays focused on transcript structure rather than delivery-related stress. This workflow connects chemically modified RNA design with the accessible-cell strategy demonstrated in fibroblast-based CRISPR activation research.
-
Berbamine Hydrochloride in Ferroptosis Research
2026-08-31
Berbamine hydrochloride offers a useful pharmacological probe for connecting NF-κB, STAT3, calcium homeostasis, and ferroptosis questions in cancer research. This evidence-led guide explains how the METTL16-SENP3-LTF study can improve assay design without overstating what is known about the compound.
-
Plerixafor (AMD3100) in Tumor Platelet Trafficking
2026-08-30
Plerixafor (AMD3100) is more than a CXCR4 inhibitor for stem cell mobilization: it can help dissect CXCL12-guided platelet entry into tumors. This article translates recent platelet-extravasation findings into practical assay and interpretation strategies.
-
EZ Cap Cy5 Firefly Luciferase mRNA: A Signal-Logic Guide
2026-08-29
EZ Cap Cy5 Firefly Luciferase mRNA enables researchers to distinguish mRNA uptake from productive cytoplasmic translation. This guide develops a signal-logic workflow for mRNA delivery and transfection, assay troubleshooting, and dual-modality imaging.
-
Nystatin (Fungicidin): A Membrane-Logic Guide
2026-08-28
Nystatin (Fungicidin) is best understood as a selective membrane-biology probe, not merely a broad antifungal control. This guide connects ergosterol-dependent fungal killing with a carefully bounded viral-entry study, helping researchers design stronger controls and interpret negative results.
-
Myelin Damage Can Remodel Before Sheath Loss
2026-08-28
Arafa et al. show that early CNS myelin damage is often marked by swelling that can resolve rather than inevitably progressing to sheath loss. Across zebrafish, rodent, and human tissue, the study identifies neuronal activity as a modifiable factor that worsens early pathology and provides a framework for testing myelin-protective interventions.
-
ExoU, Lipid Metabolism, and Host Cell Death
2026-08-27
The University of Ottawa thesis investigates how the Pseudomonas aeruginosa toxin ExoU connects phospholipase activity, host lipid remodeling, and cytotoxicity. Its most direct mechanistic finding is that ExoU-expressing bacteria increase lysophosphatidylcholine levels in host cells, while pharmacological tests argue against apoptosis or necroptosis as the dominant explanation for early cell death.
-
Nanoparticle Uptake in Human Corneal Epithelium
2026-08-27
This 2024 ACS study systematically links PLGA nanoparticle size and surface chemistry to uptake by human corneal epithelial cells. Using a mucosal in vitro model and pathway inhibitors, it identifies energy-dependent endocytosis, especially macropinocytosis and caveolae-mediated uptake, as the dominant mechanisms.
-
Autophagy–Liver Metastasis Signature in CRC
2026-08-26
Bai et al. integrated bulk and single-cell transcriptomic data to develop a six-gene colorectal cancer signature associated with autophagy, liver metastasis, prognosis, and immune dysfunction. The study links high-risk classification with immunosuppressive macrophage and CD8+ T-cell states, while providing a framework for evaluating treatment response and tumor microenvironment heterogeneity.
-
Neomycin sulfate: Workflow for Structure Studies
2026-08-26
Neomycin sulfate is an aminoglycoside antibiotic that can serve as a mechanistic probe for RNA, DNA, and ion-channel experiments—not merely as a generic antimicrobial. This workflow connects concentration-controlled binding assays with ribozyme, HIV-1 TAR, DNA triplex, and ryanodine receptor applications while emphasizing controls, fresh aqueous preparation, and cross-domain limitations.
-
BIBP 3226 Trifluoroacetate: Cardiac Assays
2026-08-25
BIBP 3226 trifluoroacetate enables pharmacological separation of NPY Y1 and NPFF signaling in cAMP, calcium, and adipose-neural models. This guide translates recent arrhythmia findings into practical workflows, concentration-planning rules, and troubleshooting strategies for cardiovascular, anxiety, and analgesia research.